table of content
1 Study Coverage
1.1 Infectious Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Preventive Vaccine
1.2.3 Therapeutic Vaccine
1.3 Market by Application
1.3.1 Global Infectious Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Pediatrics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infectious Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Infectious Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Infectious Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Infectious Vaccines Sales by Region
2.4.1 Global Infectious Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Infectious Vaccines by Region (2023-2028)
2.5 Global Infectious Vaccines Revenue by Region
2.5.1 Global Infectious Vaccines Revenue by Region (2017-2022)
2.5.2 Global Infectious Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Infectious Vaccines Sales by Manufacturers
3.1.1 Global Top Infectious Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Infectious Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infectious Vaccines in 2021
3.2 Global Infectious Vaccines Revenue by Manufacturers
3.2.1 Global Infectious Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Infectious Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Vaccines Revenue in 2021
3.3 Global Infectious Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infectious Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Infectious Vaccines Sales by Type
4.1.1 Global Infectious Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Infectious Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Infectious Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Infectious Vaccines Revenue by Type
4.2.1 Global Infectious Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Infectious Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Infectious Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Infectious Vaccines Price by Type
4.3.1 Global Infectious Vaccines Price by Type (2017-2022)
4.3.2 Global Infectious Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Infectious Vaccines Sales by Application
5.1.1 Global Infectious Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Infectious Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Infectious Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Infectious Vaccines Revenue by Application
5.2.1 Global Infectious Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Infectious Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Infectious Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Infectious Vaccines Price by Application
5.3.1 Global Infectious Vaccines Price by Application (2017-2022)
5.3.2 Global Infectious Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Infectious Vaccines Market Size by Type
6.1.1 North America Infectious Vaccines Sales by Type (2017-2028)
6.1.2 North America Infectious Vaccines Revenue by Type (2017-2028)
6.2 North America Infectious Vaccines Market Size by Application
6.2.1 North America Infectious Vaccines Sales by Application (2017-2028)
6.2.2 North America Infectious Vaccines Revenue by Application (2017-2028)
6.3 North America Infectious Vaccines Market Size by Country
6.3.1 North America Infectious Vaccines Sales by Country (2017-2028)
6.3.2 North America Infectious Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Infectious Vaccines Market Size by Type
7.1.1 Europe Infectious Vaccines Sales by Type (2017-2028)
7.1.2 Europe Infectious Vaccines Revenue by Type (2017-2028)
7.2 Europe Infectious Vaccines Market Size by Application
7.2.1 Europe Infectious Vaccines Sales by Application (2017-2028)
7.2.2 Europe Infectious Vaccines Revenue by Application (2017-2028)
7.3 Europe Infectious Vaccines Market Size by Country
7.3.1 Europe Infectious Vaccines Sales by Country (2017-2028)
7.3.2 Europe Infectious Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Infectious Vaccines Market Size by Type
8.1.1 Asia Pacific Infectious Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Infectious Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Infectious Vaccines Market Size by Application
8.2.1 Asia Pacific Infectious Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Infectious Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Infectious Vaccines Market Size by Region
8.3.1 Asia Pacific Infectious Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Infectious Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Infectious Vaccines Market Size by Type
9.1.1 Latin America Infectious Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Infectious Vaccines Revenue by Type (2017-2028)
9.2 Latin America Infectious Vaccines Market Size by Application
9.2.1 Latin America Infectious Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Infectious Vaccines Revenue by Application (2017-2028)
9.3 Latin America Infectious Vaccines Market Size by Country
9.3.1 Latin America Infectious Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Infectious Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Infectious Vaccines Market Size by Type
10.1.1 Middle East and Africa Infectious Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Infectious Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Infectious Vaccines Market Size by Application
10.2.1 Middle East and Africa Infectious Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Infectious Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Infectious Vaccines Market Size by Country
10.3.1 Middle East and Africa Infectious Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Infectious Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL Limited (Australia)
11.1.1 CSL Limited (Australia) Corporation Information
11.1.2 CSL Limited (Australia) Overview
11.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Limited (Australia) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Limited (Australia) Recent Developments
11.2 Bavarian Nordic (Denmark)
11.2.1 Bavarian Nordic (Denmark) Corporation Information
11.2.2 Bavarian Nordic (Denmark) Overview
11.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic (Denmark) Recent Developments
11.3 GlaxoSmithKline plc. (U.K.)
11.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
11.3.2 GlaxoSmithKline plc. (U.K.) Overview
11.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline plc. (U.K.) Recent Developments
11.4 Emergent Bio Solutions Inc. (U.S.)
11.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
11.4.2 Emergent Bio Solutions Inc. (U.S.) Overview
11.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Developments
11.5 MedImmune LLC (U.S.)
11.5.1 MedImmune LLC (U.S.) Corporation Information
11.5.2 MedImmune LLC (U.S.) Overview
11.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 MedImmune LLC (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 MedImmune LLC (U.S.) Recent Developments
11.6 Johnson and Johnson (U.S.)
11.6.1 Johnson and Johnson (U.S.) Corporation Information
11.6.2 Johnson and Johnson (U.S.) Overview
11.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson and Johnson (U.S.) Recent Developments
11.7 Novartis AG (Switzerland)
11.7.1 Novartis AG (Switzerland) Corporation Information
11.7.2 Novartis AG (Switzerland) Overview
11.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis AG (Switzerland) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis AG (Switzerland) Recent Developments
11.8 Merck and Company (U.S.)
11.8.1 Merck and Company (U.S.) Corporation Information
11.8.2 Merck and Company (U.S.) Overview
11.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck and Company (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck and Company (U.S.) Recent Developments
11.9 Sanofi Pasteur (France)
11.9.1 Sanofi Pasteur (France) Corporation Information
11.9.2 Sanofi Pasteur (France) Overview
11.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Pasteur (France) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Pasteur (France) Recent Developments
11.10 Pfizer Inc. (U.S.)
11.10.1 Pfizer Inc. (U.S.) Corporation Information
11.10.2 Pfizer Inc. (U.S.) Overview
11.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Inc. (U.S.) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Infectious Vaccines Industry Chain Analysis
12.2 Infectious Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infectious Vaccines Production Mode & Process
12.4 Infectious Vaccines Sales and Marketing
12.4.1 Infectious Vaccines Sales Channels
12.4.2 Infectious Vaccines Distributors
12.5 Infectious Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infectious Vaccines Industry Trends
13.2 Infectious Vaccines Market Drivers
13.3 Infectious Vaccines Market Challenges
13.4 Infectious Vaccines Market Restraints
14 Key Findings in The Global Infectious Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
